Discontinuation of Trimethoprim/sulfamethoxazole Prophylaxis Due to Hyperkalemia in Kidney Transplant Recipients

被引:0
|
作者
Pett, D. [1 ]
Malat, G. [2 ]
Domenico, C. [1 ]
Samudralwar, R. [1 ]
Forte, A. [1 ]
Sawinski, D. [2 ]
Hu, J. [1 ]
Steiner, B. [1 ]
Rashid, J. [1 ]
Trofe-Clark, J. [2 ]
机构
[1] Hosp Univ Penn, Pharm, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Penn Transplant Inst, 3400 Spruce St, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
795
引用
收藏
页码:634 / 634
页数:1
相关论文
共 50 条
  • [1] Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients
    Muñoz, P
    Arencibia, J
    Rodríguez, C
    Rivera, M
    Palomo, J
    Yañez, J
    Bouza, E
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) : 932 - 933
  • [2] Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients - Reply
    Montoya, JG
    Remington, JS
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) : 933 - 933
  • [3] LIFELONG PROPHYLAXIS WITH TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PREVENTION OF OUTBREAK OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN KIDNEY TRANSPLANT RECIPIENTS
    Goto, Norihiko
    Takahashi-Nakazato, Ai
    Futamura, Kenta
    Okada, Manabu
    Tsujita, Makoto
    Hiramitsu, Takahisa
    Narumi, Shunji
    Oka, Shinichi
    Watarai, Yoshihiko
    TRANSPLANT INTERNATIONAL, 2017, 30 : 309 - 309
  • [4] Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients
    Zmarlicka, Monika
    Martin, Spencer T.
    Cardwell, Sophia M.
    Nailor, Michael D.
    PROGRESS IN TRANSPLANTATION, 2015, 25 (03) : 210 - 216
  • [5] TRIMETHOPRIM-SULFAMETHOXAZOLE PHARMACOKINETIC EVALUATION IN ADULT KIDNEY TRANSPLANT RECIPIENTS
    Scuderi, C.
    Jahan, S.
    Parker, S.
    Wallis, S.
    Jacks, M.
    John, G.
    Mcwhinney, B.
    Ungerer, J.
    Mallett, A.
    Healy, H.
    Roberts, J.
    Staatz, C.
    NEPHROLOGY, 2021, 26 : 16 - 16
  • [6] Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole
    Koç, M
    Bihorac, A
    Özener, ÇI
    Kantarci, G
    Akoglu, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03)
  • [7] Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney transplant
    Horwedel, T. A.
    Bowman, L. J.
    Saab, G.
    Brennan, D. C.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (02) : 261 - 269
  • [8] Trimethoprim-Sulfamethoxazole and Hyperkalemia
    Smith, Cynthia A.
    NEPHROLOGY NURSING JOURNAL, 2021, 48 (02) : 177 - 180
  • [9] Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies.
    Aldag, E.
    Pagels, C.
    Pedersen, R.
    Nadeem, I.
    Gunabushanam, V.
    Sahajpal, A.
    Dilworth, T. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 728 - 728
  • [10] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA WITH TRIMETHOPRIM/SULFAMETHOXAZOLE OR PENTAMIDINE PROPHYLAXIS IN CARDIAC TRANSPLANT RECIPIENTS
    EISEN, HJ
    MULL, RL
    BRENNAN, PJ
    DISESA, VJ
    CLINICAL RESEARCH, 1994, 42 (03): : A445 - A445